AUC passes, Cmax fails: biopharmaceutical difference [PK / PD]

posted by Helmut Homepage – Vienna, Austria, 2021-03-23 12:03 (1331 d 04:57 ago) – Posting: # 22292
Views: 2,159

Merhaba akif,

❝ I want to know that why while auc with in spect Cmax out of it? its means that test has higher dissolution rate everytime, …


Only if your drug is in BCS class I or – under certain conditions – in class III, dissolution plays a major rule. If in class II/IV, dissolution is not predictive. There are a manifold of reasons with the absorption rate differs between products. Even if excipients and their amount are identical, differences in the manufacturing process may explain the different absorption.

❝ … or can cause another thing such as CRO, …


No.

❝ … design of study, …


Only if you have problems with a “first point Cmax”.

❝ … bioanalytical method?


No.

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
23,297 posts in 4,892 threads, 1,693 registered users;
29 visitors (0 registered, 29 guests [including 8 identified bots]).
Forum time: 17:00 CET (Europe/Vienna)

Laws are like sausages – it is better
not to see them being made.    Otto von Bismarck

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5